YOLFTbeta
Nexentis Technologies Inc.

Nexentis Technologies Inc.

NXTS · NASDAQ · Basic Materials / Agricultural Inputs

2.21USD+0.20 (+9.95%)

Price History

Full chart

Market Stats

Previous Close2.01
Open2.06
Day Range2.06 – 2.22
52-Week Range1.14 – 32.90
Volume7.66K
Market Cap2.14M
P/E (TTM)0.08
Forward P/E0.00
EPS17.39
Dividend Yield0.00%
Beta1.87
50-Day Avg1.78
200-Day Avg6.02

About

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.

Company Details

  • SectorBasic Materials
  • IndustryAgricultural Inputs
  • CEOMr. David Palach
  • Employees7
  • HeadquartersPinhas Sapir St. 3, Ness Ziona, Israel, 7403626, USA
  • Websitehttps://www.nexentistech.com

Leadership

  • Mr. David PalachChief Executive Officer · b. 1966
  • Ms. Lital BardaCFO, Financial Controller, Treasurer & Secretary · b. 1987
  • Ms. Galit KenigsbergHead of Sustainability Operations of scientific advisory board

Financials

Income Statement

Currency: USD2009-12-312010-12-312011-12-312012-12-312013-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue96.51K274.00K460.09K351.40K522.10K321.97K343.93K426.59K175.82K232.27K438.14K394.00K263.44K210.00K0
Growth (%)-+183.92%+67.92%-23.62%+48.58%-38.33%+6.82%+24.04%-58.78%+32.11%+88.63%-10.07%-33.14%-20.29%-100.00%
Cost of Revenue61.29K41.35K---245.94K141.77K136.84K171.90K88.61K194.15K188.46K76.33K177.00K79.00K
Gross Profit35.22K232.65K---76.03K202.15K289.75K3.92K143.66K243.99K205.54K187.11K33.00K-79.00K
Gross Margin36.49%84.91%---23.61%58.78%67.92%2.23%61.85%55.69%52.17%71.02%15.71%-
Operating Expense1.11M806.26K---1.01M896.31K771.71K1.94M1.49M4.79M5.92M7.49M4.08M4.15M
Operating Income-1.08M-573.61K-537.19K-632.73K-410.67K-937.57K-694.15K-481.96K-1.93M-1.35M-4.54M-5.71M-7.30M-4.05M-4.23M
Operating Margin-1114.05%-209.35%-116.76%-180.06%-78.66%-291.20%-201.83%-112.98%-1098.44%-580.93%-1036.84%-1449.43%-2771.52%-1928.10%-
EBITDA-1.07M-566.18K-528.50K-625.36K-403.20K-917.76K-677.42K-443.07K-1.90M-1.30M-4.48M-5.66M-7.28M-4.03M-3.42M
EBITDA Margin-1106.27%-206.64%-114.87%-177.96%-77.23%-285.05%-196.97%-103.86%-1082.88%-561.47%-1023.56%-1435.55%-2763.49%-1919.52%-
Net Income-1.08M-629.04K-606.87K-695.74K-468.81K-599.49K-672.14K-356.89K-1.97M-1.59M-4.82M-5.74M-6.52M-5.19M-4.00M
Net Income Margin-1115.60%-229.58%-131.90%-197.99%-89.79%-186.20%-195.43%-83.66%-1121.25%-685.89%-1100.23%-1456.74%-2475.81%-2472.86%-
R&D756.92K561.47K691.59K682.63K707.44K323.91K308.85K296.28K595.08K387.68K500.52K748.79K1.93M367.00K179.00K
R&D as % of Total Revenue784.32%204.92%150.32%194.26%135.50%100.60%89.80%69.45%338.45%166.91%114.24%190.05%730.81%174.76%-
Interest Expense1.50K55.42K69.67K63.02K58.14K18.20K21.25K-43.41K209.15K44.55K8.80K5.36K95.00K114.00K
Interest Expense % of Total Revenue1.55%20.23%15.14%17.93%11.14%5.65%6.18%-24.69%90.04%10.17%2.23%2.03%45.24%-

Balance Sheet

Currency: USD2009-12-312010-12-312011-12-312012-12-312013-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets130.28K281.58K327.35K312.84K360.66K438.98K535.43K859.21K664.67K687.65K7.60M6.49M7.24M5.46M20.41M
Total Liabilities386.92K699.93K560.36K1.20M1.11M1.28M1.27M647.70K1.07M1.15M1.18M754.87K785.65K892.00K4.67M
Total Equity-256.64K-418.36K-233.01K-886.20K-746.71K-562.44K-438.72K218.23K-381.07K-436.18K6.48M5.85M6.48M4.75M16.01M
Cash--22.45K33.48K13.08K4.51K28.32K439.81K329.01K265.30K6.81M5.75M4.48M2.21M3.83M
Total Debt9.11K189.49K174.36K187.18K346.58K496.50K460.30K61.07K360.19K234.29K225.71K146.36K54.88K7.00K992.00K
Net Debt9.11K189.49K151.91K153.69K333.50K491.99K431.98K-378.74K31.19K-31.00K-6.58M-5.60M-4.42M-2.20M-2.84M

Cash Flow

Currency: USD2009-12-312010-12-312011-12-312012-12-312013-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-847.77K-430.89K-660.17K-540.99K-129.33K-650.99K-623.23K-506.50K-1.24M-798.74K-4.10M-5.10M-3.23M-3.42M-3.81M
Investing Cash Flow-26.68K-33.16K-12.87K-21.02K-26.61K262.50K292.30K5.78K-43.46K-6.73K-82.79K-51.69K-1.52M-1.89M-3.23M
Financing Cash Flow603.64K464.05K695.49K573.40K135.54K100.00K354.73K912.21K1.18M741.76K10.73M4.09M3.47M3.05M8.86M
Capital Expenditure13.68K17.26K1.71K4.87K15.16K054.48K2.53K23.33K067.75K51.69K1014.00K
Free Cash Flow-861.45K-448.15K-661.88K-545.86K-144.49K-650.99K-677.71K-509.03K-1.27M-798.74K-4.17M-5.15M-3.23M-3.42M-3.82M
FCF to OCF101.61%104.01%100.26%100.90%111.72%100.00%108.74%100.50%101.87%100.00%101.65%101.01%100.00%100.00%100.37%

Earnings

Report DateMar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 15, 2025Jun 30, 2025Sep 30, 2025Mar 31, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate-----------------------------------------------
EPS Actual-4801.70-4926.67-3679.91-616.64-3044.14-5441.16-3332.20-2834.22-1399.34-3014.99-3207.30-1509.46-2710.80-47.41-47.41-308.05-287.89-448.53-653.51-606.95-663.17-429.95-678.53-477.69-231.13-525.57-1176.83-792.17-953.06-808.91-752.89-815.15-517.97-629.56-174.18-3047.92-181.12-63.68-56.59-95.27-27.89-0.39-44.393.18-10.74-25.96-
Surprise-----------------------------------------------
Timing-----------------------------------------------

Key Statistics & Ratios

Market Cap2.14M
Enterprise Value-6.17M
Trailing P/E0.08
Forward P/E0.00
Price / Sales4.32
Price / Book1.20
EPS17.39
Book Value1.31
Revenue (TTM)209.00K
Gross Profit (TTM)2.00K
EBITDA-5.97M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-454.82%
Return on Assets-29.54%
Shares Outstanding1.45M
Shares Float1.14M
Beta1.87
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
4.36%
Insiders
21.17%
Retail / Other
74.47%

Top Institutional Holders

  • Yorkville Advisors Global, LP
    16.41K1.13%
  • SBI Securities Co Ltd
    580.00%
  • Tower Research Capital LLC
    00.00%
  • Bank of America Corp
    00.00%
  • Citadel Advisors Llc
    00.00%
  • UBS Group AG
    00.00%
  • DRW Securities, LLC
    00.00%
  • Morgan Stanley - Brokerage Accounts
    00.00%
  • Bank Julius Baer & Co. Ltd, Zurich
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    3.06K0.21%
  • Fidelity Series Total Market Index
    970.01%

Stock Splits

  • Nov 9, 20261:5
  • Apr 8, 20261:7
  • Sep 22, 20251:35
  • Oct 6, 20231:7
  • Feb 25, 20211:7
  • Jun 13, 20191:15